MARKET

ATHX

ATHX

Athersys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.410
+0.100
+4.33%
After Hours: 2.450 +0.04 +1.66% 19:35 08/13 EDT
OPEN
2.290
PREV CLOSE
2.310
HIGH
2.420
LOW
2.280
VOLUME
1.52M
TURNOVER
--
52 WEEK HIGH
4.380
52 WEEK LOW
1.130
MARKET CAP
475.74M
P/E (TTM)
-7.9749
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ATHX stock price target is 9.00 with a high estimate of 14.00 and a low estimate of 5.00.

EPS

ATHX News

More
Athersys Q2 EPS $(0.10) Misses $(0.08) Estimate, Sales $84.00K Down From $4.26M YoY
Athersys (NASDAQ:ATHX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 66.67 percent decrease over losses of $(0.06) per share from the same
Benzinga · 3d ago
Athersys to Host Second Quarter Financial Results Call
Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2020 financial results on Monday, August 10, 2020.
Business Wire · 07/20 18:00
Afternoon Market Stats in 5 Minutes
Movers Indices • S&P 500 ETF (NYSE:SPY) fell 0.10% to $303.98. • Nasdaq ETF (NASDAQ:QQQ) increased 0.03% to $243.78. • Dow Jones Industrial Average ETF (NYSE:DIA) fell 0.01% to $254.61.
Benzinga · 06/25 16:20
Benzinga's Top Upgrades, Downgrades For June 25, 2020
Benzinga · 06/25 15:10
B of A Securities Initiates Coverage On Athersys with Buy Rating, Announces Price Target of $5
B of A Securities analyst Greg Harrison initiates coverage on Athersys (NASDAQ:ATHX) with a Buy rating and announces Price Target of $5.
Benzinga · 06/25 12:35
RAD, INO among premarket gainers
Seeking Alpha - Article · 06/25 12:14
Here's Why Athersys Stock Is Soaring Today
MotleyFool.com · 06/25 04:00
Hedge Funds Getting Bullish On Athersys, Inc. (ATHX)
Insider Monkey · 06/22 19:54

Industry

Biotechnology & Medical Research
+1.09%
Pharmaceuticals & Medical Research
-0.01%

Hot Stocks

Symbol
Price
%Change

About ATHX

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
More

Webull offers kinds of Athersys Inc stock information, including NASDAQ:ATHX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATHX stock methods without spending real money on the virtual paper trading platform.